Immix Is a Clinical-Stage Biopharmaceutical Co Developing Cell Therapies in Autoimmune Disease >IMMX
Immix Is a Clinical-Stage Biopharmaceutical Co Developing Cell Therapies in Autoimmune Disease >IMMX
Immix 是一家臨床階段的生物製藥公司，開發自身免疫性疾病的細胞療法 >IMMX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊